Sintx Technologies, Inc. (SINT)
Nasdaq · Healthcare · Medical Devices
$2.18−1.36%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $14.5M
- 52-week range
- $1.40 – $4.64
- 52-week change
- −47.51%
- EPS (trailing)
- −$4.91
- Analyst rating
- 1.3 Strong buy
Fiscal year to Dec 2025
- Revenue
- $1.0M (−64.74%)
- Net income
- −$10.4M
- Operating margin
- −1053.1%
- Diluted EPS
- −$6.16
- Free cash flow
- −$8.8M
From the company’s annual report on SEC EDGAR.
About Sintx Technologies, Inc.
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Headquarters: Salt Lake City, United States · 32 employees · sintx.com